Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
CA Cancer J Clin ; 66(3): 203-39, 2016 05.
Artículo en Inglés | MEDLINE | ID: mdl-27002678

RESUMEN

Answer questions and earn CME/CNE The American Cancer Society Head and Neck Cancer Survivorship Care Guideline was developed to assist primary care clinicians and other health practitioners with the care of head and neck cancer survivors, including monitoring for recurrence, screening for second primary cancers, assessment and management of long-term and late effects, health promotion, and care coordination. A systematic review of the literature was conducted using PubMed through April 2015, and a multidisciplinary expert workgroup with expertise in primary care, dentistry, surgical oncology, medical oncology, radiation oncology, clinical psychology, speech-language pathology, physical medicine and rehabilitation, the patient perspective, and nursing was assembled. While the guideline is based on a systematic review of the current literature, most evidence is not sufficient to warrant a strong recommendation. Therefore, recommendations should be viewed as consensus-based management strategies for assisting patients with physical and psychosocial effects of head and neck cancer and its treatment. CA Cancer J Clin 2016;66:203-239. © 2016 American Cancer Society.


Asunto(s)
Cuidados Posteriores , Neoplasias de Cabeza y Cuello/terapia , Sobrevivientes , Enfermedades del Nervio Accesorio/diagnóstico , Enfermedades del Nervio Accesorio/terapia , American Cancer Society , Ansiedad/diagnóstico , Ansiedad/psicología , Ansiedad/terapia , Bursitis/diagnóstico , Bursitis/terapia , Trastornos de Deglución/diagnóstico , Trastornos de Deglución/terapia , Atención Odontológica , Caries Dental/diagnóstico , Caries Dental/terapia , Depresión/diagnóstico , Depresión/psicología , Depresión/terapia , Manejo de la Enfermedad , Distonía/diagnóstico , Distonía/terapia , Fatiga/diagnóstico , Fatiga/terapia , Reflujo Gastroesofágico/diagnóstico , Reflujo Gastroesofágico/terapia , Neoplasias de Cabeza y Cuello/psicología , Promoción de la Salud , Humanos , Hipotiroidismo/diagnóstico , Hipotiroidismo/terapia , Linfedema/diagnóstico , Linfedema/terapia , Músculos del Cuello , Osteonecrosis/diagnóstico , Osteonecrosis/terapia , Periodontitis/diagnóstico , Periodontitis/terapia , Enfermedades del Sistema Nervioso Periférico/diagnóstico , Enfermedades del Sistema Nervioso Periférico/terapia , Aspiración Respiratoria/diagnóstico , Aspiración Respiratoria/terapia , Síndromes de la Apnea del Sueño/diagnóstico , Síndromes de la Apnea del Sueño/terapia , Trastornos del Sueño-Vigilia/diagnóstico , Trastornos del Sueño-Vigilia/terapia , Estrés Psicológico/diagnóstico , Estrés Psicológico/psicología , Estrés Psicológico/terapia , Trastornos del Gusto/diagnóstico , Trastornos del Gusto/terapia , Trismo/diagnóstico , Trismo/terapia
2.
CA Cancer J Clin ; 65(6): 428-55, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26348643

RESUMEN

Colorectal cancer (CRC) is the third most common cancer and third leading cause of cancer death in both men and women and second leading cause of cancer death when men and women are combined in the United States (US). Almost two-thirds of CRC survivors are living 5 years after diagnosis. Considering the recent decline in both incidence and mortality, the prevalence of CRC survivors is likely to increase dramatically over the coming decades with the increase in rates of CRC screening, further advances in early detection and treatment and the aging and growth of the US population. Survivors are at risk for a CRC recurrence, a new primary CRC, other cancers, as well as both short-term and long-term adverse effects of the CRC and the modalities used to treat it. CRC survivors may also have psychological, reproductive, genetic, social, and employment concerns after treatment. Communication and coordination of care between the treating oncologist and the primary care clinician is critical to effectively and efficiently manage the long-term care of CRC survivors. The guidelines in this article are intended to assist primary care clinicians in delivering risk-based health care for CRC survivors who have completed active therapy.


Asunto(s)
Neoplasias Colorrectales/terapia , Atención Primaria de Salud , Sobrevivientes , Cuidados Posteriores , Neoplasias Colorrectales/complicaciones , Neoplasias Colorrectales/diagnóstico , Neoplasias Colorrectales/psicología , Detección Precoz del Cáncer/métodos , Femenino , Promoción de la Salud , Humanos , Comunicación Interdisciplinaria , Masculino , Recurrencia Local de Neoplasia/diagnóstico , Neoplasias Primarias Secundarias/diagnóstico , Grupo de Atención al Paciente , Calidad de Vida , Sobrevivientes/psicología
3.
CA Cancer J Clin ; 64(4): 225-49, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24916760

RESUMEN

Prostate cancer survivors approach 2.8 million in number and represent 1 in 5 of all cancer survivors in the United States. While guidelines exist for timely treatment and surveillance for recurrent disease, there is limited availability of guidelines that facilitate the provision of posttreatment clinical follow-up care to address the myriad of long-term and late effects that survivors may face. Based on recommendations set forth by a National Cancer Survivorship Resource Center expert panel, the American Cancer Society developed clinical follow-up care guidelines to facilitate the provision of posttreatment care by primary care clinicians. These guidelines were developed using a combined approach of evidence synthesis and expert consensus. Existing guidelines for health promotion, surveillance, and screening for second primary cancers were referenced when available. To promote comprehensive follow-up care and optimal health and quality of life for the posttreatment survivor, the guidelines address health promotion, surveillance for prostate cancer recurrence, screening for second primary cancers, long-term and late effects assessment and management, psychosocial issues, and care coordination among the oncology team, primary care clinicians, and nononcology specialists. A key challenge to the development of these guidelines was the limited availability of published evidence for management of prostate cancer survivors after treatment. Much of the evidence relies on studies with small sample sizes and retrospective analyses of facility-specific and population databases.


Asunto(s)
Continuidad de la Atención al Paciente/normas , Atención Primaria de Salud/normas , Neoplasias de la Próstata/terapia , Sobrevivientes , American Cancer Society , Medicina Basada en la Evidencia , Promoción de la Salud/normas , Humanos , Masculino , Vigilancia de la Población , Calidad de Vida , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA